| Ann Casey Gioeli, PT | |
|
436 Central Ave, Oak Hill, WV 25901-3009 | |
| (304) 465-3654 | |
| (304) 465-8551 |
| Full Name | Ann Casey Gioeli |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 436 Central Ave, Oak Hill, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063495588 | NPI | - | NPPES |
| 0157196-000 | Medicaid | WV | |
| 1043802 | Other | WV | WV WORKERS COMPENSATION |
| 0157196-000 | Other | WV | MOUNTAIN STATE BC/BS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 001326 (West Virginia) | Primary |
| Provider Name | Martha Jefferson House |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1093445165 PECOS PAC ID: 6406236967 Enrollment ID: O20220630002101 |
News Archive
The Ontario Institute for Cancer Research (OICR) will receive $420 million over five years from the Government of Ontario to continue its research into the prevention, early detection, diagnosis and treatment of cancer.
In a new research our worst fears are confirmed – fatty, fried and fattening foods are addictive. The addiction with these delicious ‘yummies' may be as potent as that with cocaine or heroin. The study was conducted on experimental animals, rats in this case. When fed with fatty foods in great quantities these rats showed a compulsive need to eat.
At the recent meeting of the American Urological Association in San Francisco, researchers presented studies regarding the decision making process men go through when considering proposed prostate cancer treatments. Dr. Vorstman, renowned Florida urologist, believes these studies would have more meaning if patients were presented with information about prostate cancer treatment options in a different fashion.
For most men with low-risk prostate cancer, the recommended strategy is active surveillance with regular testing to check for cancer growth rather than immediate treatment, according to guidelines from the American Society of Clinical Oncology.
ARIAD Pharmaceuticals, Inc. today announced the initiation of the pivotal Phase 2 clinical trial of its investigational pan-BCR-ABL inhibitor, ponatinib (previously known as AP24534), in patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia positive acute lymphoblastic leukemia (Ph+ ALL).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ann Casey Gioeli, PT 436 Central Ave, Oak Hill, WV 25901-3009 Ph: (304) 465-3654 | Ann Casey Gioeli, PT 436 Central Ave, Oak Hill, WV 25901-3009 Ph: (304) 465-3654 |
News Archive
The Ontario Institute for Cancer Research (OICR) will receive $420 million over five years from the Government of Ontario to continue its research into the prevention, early detection, diagnosis and treatment of cancer.
In a new research our worst fears are confirmed – fatty, fried and fattening foods are addictive. The addiction with these delicious ‘yummies' may be as potent as that with cocaine or heroin. The study was conducted on experimental animals, rats in this case. When fed with fatty foods in great quantities these rats showed a compulsive need to eat.
At the recent meeting of the American Urological Association in San Francisco, researchers presented studies regarding the decision making process men go through when considering proposed prostate cancer treatments. Dr. Vorstman, renowned Florida urologist, believes these studies would have more meaning if patients were presented with information about prostate cancer treatment options in a different fashion.
For most men with low-risk prostate cancer, the recommended strategy is active surveillance with regular testing to check for cancer growth rather than immediate treatment, according to guidelines from the American Society of Clinical Oncology.
ARIAD Pharmaceuticals, Inc. today announced the initiation of the pivotal Phase 2 clinical trial of its investigational pan-BCR-ABL inhibitor, ponatinib (previously known as AP24534), in patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia positive acute lymphoblastic leukemia (Ph+ ALL).
› Verified 5 days ago
Ashley Brooke Poland, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 436 Central Ave, Oak Hill, WV 25901 Phone: 304-465-3654 Fax: 304-465-8551 | |
Winston Caleb O'neal, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 436 Central Ave, Oak Hill, WV 25901 Phone: 304-465-3654 | |
Jenelle M Canterbury, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 438 23rd St, The Summit At Hidden Valley, Oak Hill, WV 25901 Phone: 304-465-1452 Fax: 304-465-8094 | |
Mr. William Charles Reilley, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 436 Central Ave, Oak Hill, WV 25901 Phone: 304-465-3654 Fax: 304-465-8551 | |
Lindsey Erin Gentry, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 422 23rd St, Oak Hill, WV 25901 Phone: 304-465-1903 Fax: 304-465-3568 | |
Lesley Nicole Powers, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 436 Central Ave, Oak Hill, WV 25901 Phone: 304-465-3654 Fax: 304-465-8551 |